Fleury
Fleury works in prevention, diagnostic and therapeutic medicine.
Launch date
Employees
Market cap
$1.6b
Enterprise valuation
$2.2b (Public information from Sep 2024)
Share price
BRL16.45 FLRY3.SA
São Paulo São Paulo (HQ)
Financials
Estimates*
BRL | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 3.0b | 3.9b | 4.5b | 6.5b | 7.8b | 8.3b | 8.8b |
% growth | 2 % | 30 % | 15 % | 45 % | 21 % | 7 % | 6 % |
EBITDA | 823m | 1.1b | 1.3b | 1.8b | 2.0b | 2.2b | 2.3b |
% EBITDA margin | 28 % | 27 % | 28 % | 28 % | 26 % | 26 % | 26 % |
Profit | 257m | 350m | 308m | 424m | 671m | 774m | 869m |
% profit margin | 9 % | 9 % | 7 % | 7 % | 9 % | 9 % | 10 % |
EV / revenue | 3.2x | 2.0x | 1.3x | 2.0x | 1.6x | 1.4x | 1.3x |
EV / EBITDA | 11.5x | 7.4x | 4.5x | 7.3x | 6.2x | 5.5x | 5.1x |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | BRL500m | Post IPO Debt | |
Total Funding | - |
Recent News about Fleury
EditInvestments by Fleury
EditACQUISITION by Fleury Apr 2021
ACQUISITION by Fleury May 2022
ACQUISITION by Fleury Oct 2022